P150-1129 Screening compound: 5-(2-furylmethyl)-2-(4-methylpiperazino)-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine

P150-1129 Screening compound: 5-(2-furylmethyl)-2-(4-methylpiperazino)-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine
P150-1129 Screening compound: 5-(2-furylmethyl)-2-(4-methylpiperazino)-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine alternative view

Chemical Structure Depiction of ChemDiv screening compound P150-1129
5-(2-furylmethyl)-2-(4-methylpiperazino)-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P150-1129

Molecular Formula

C16H22N4OS (C16 H22 N4 OS)

Compound Name

5-(2-furylmethyl)-2-(4-methylpiperazino)-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine

IUPAC name

1-{5-[(furan-2-yl)methyl]-4H5H6H7H-[13]thiazolo[54-c]pyridin-2-yl}-4-methylpiperazine

SMILES

CN(CC1)CCN1c1nc(CCN(Cc2ccco2)C2)c2s1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

318.44

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

2.276

Distribution Coefficient, logD

0.715

Water Solubility, LogSw

-2.55

Polar Surface Area

29.632

Acid Dissociation Constant (pKa)

23.08

Base Dissociation Constant (pKb)

8.95

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

56.25

P150-1129 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Soluble Diversity Library (15920 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
Targets:
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Epigenetic
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with P150-1129 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P150-1129?
Check Price and Availability of P150-1129, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P150-1129 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P150-1129
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P150-1129
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P150-1129 available by request